In order to obtain this action we must pay 32,48$ right now, Cymabay Therapeu is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Charles A. McWherter (Chief Scientific Officer & Senior Vice President), Dennis D. Kim (Chief Medical Officer), Sujal Shah (President, Chief Executive Officer & Director) and its address is 7575 GATEWAY BOULEVARD SUITE 110, NEWARK, California, 94560, United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 32,48$ - 32,50$, with a percentage difference of 32,49$ quite wide that helps to be able to do day trading.
He earns an annual income of desconocido.
The last value we have registered for the opening is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.